FDA approved the cobas KRAS Mutation Test for diagnostic use.
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
FDA approves cobas KRAS mutation test
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
The Cancer Letter’s summer reading list is here and it’s full of titles to help you drive professional growth, reflect on a divided nation—and even explore a little “neural nostalgia” with Beyoncé.
In June 2020, I was seeing consults in the damp, windowless basement of a community hospital in North Carolina.
I accumulated some books I found interesting over the last several months, knowing I would eventually take time off on vacation and have a chance to delve into them more than my schedule normally allows.
In this country, we have museums devoted to natural history, culture, space exploration, sports, civil rights, and all manner of creative expression. But surprisingly, one of our nation’s most important human endeavors—the quest to translate scientific discoveries into medical advances—lacks a national venue that captures the drama of its story.
Cancer does not discriminate. It can affect poor and rich, old and young, ordinary people and celebrities, and people from all walks of life. The diagnosis of cancer is almost always unexpected, sudden, and shocking, independent of social status, education, or profession.
